🇺🇸 FDA

Company profile · Sponsor

Cassiopea

Cassiopea S.p.A.

E501831 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Cassiopea (E501831) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E501831
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in comparison to three marketed topical corticosteroids

    Cassiopea

    Test of vasocontriction properties for classification of topical steroid potency

    phase 1 other active

    1 trial

Frequently asked questions

What is Cassiopea?

Cassiopea (E501831) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Cassiopea sponsor?

We track 1 ClinicalTrials.gov-linked program for Cassiopea, including Assessment of narrowing of blood vessels after single application of two clascoterone formulations (cream and solution) onto the skin in comparison to three marketed topical corticosteroids. Open each program for phase, modality, NCT IDs, and indication details.

Where does Cassiopea company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.